Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04907851
Title A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) (KEYNOTE-E86)
Acronym KEYNOTE-E86
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Redx Pharma Plc
Age Groups: adult | senior
Covered Countries GBR | AUS

Facility Status City State Zip Country Details
Wollongong Hospital Wollongong New South Wales 2500 Australia Details
The Alfred Hospital - Alfred Health Melbourne Victoria 3304 Australia Details
Cambridge University Hospital NHS Foundation Trust Cambridge CB2 0XY United Kingdom Details
Beatson West of Scotland Cancer Care Glasgow G12 0YN United Kingdom Details
St James University Hospital Leeds LS9 7TF United Kingdom Details
Barts Cancer Institute - Haemato-Oncology London EC1M 6BQ United Kingdom Details
University College Hospitals NHS Foundation Trust London NW1 2BU United Kingdom Details
Royal Free London Foundation NHS Trust London NW3 2QG United Kingdom Details
Imperial College Healthcare NHS Trust - Hammersmith Hospital London W12 0HS United Kingdom Details
The Christie NHS Foundation Trust - Medical Oncology Manchester M20 4BX United Kingdom Details
Oxford Cancer and Haematology Centre Churchill Hospital Oxford OX3 7LE United Kingdom Details
Weston Park Hospital Sheffield S10 2SJ United Kingdom Details
The Royal Marsden Hospital (Surrey) Sutton SM25PT United Kingdom Details
*Shaded cells indicate that there was no data available from for the field